Updated Jul 16, 2026
Posard Matthew L. has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-07 | HALO | HALOZYME THERAPEUTICS, INC. | A — Grant or award | 3.8K | $0.00 | |
| 2025-05-01 | HALO | HALOZYME THERAPEUTICS, INC. | A — Grant or award | 4.2K | $0.00 |
Posard Matthew L. is a corporate insider — currently tracked as Director of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Posard Matthew L. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.